BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 16505267)

  • 1. Incidence of venous thromboembolism and its effect on survival among patients with common cancers.
    Chew HK; Wun T; Harvey D; Zhou H; White RH
    Arch Intern Med; 2006 Feb; 166(4):458-64. PubMed ID: 16505267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in ovarian cancer.
    Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
    Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
    Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
    Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.
    White RH; Chew HK; Zhou H; Parikh-Patel A; Harris D; Harvey D; Wun T
    Arch Intern Med; 2005 Aug 8-22; 165(15):1782-7. PubMed ID: 16087828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    White RH; Chew H; Wun T
    Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
    Schulman S; Lindmarker P
    N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of cancers associated with venous thromboembolism.
    Sørensen HT; Mellemkjaer L; Olsen JH; Baron JA
    N Engl J Med; 2000 Dec; 343(25):1846-50. PubMed ID: 11117976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma and venous thromboembolism: influence on mortality.
    Mahajan A; Wun T; Chew H; White RH
    Thromb Res; 2014 May; 133 Suppl 2():S23-8. PubMed ID: 24862141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
    Lin J; Proctor MC; Varma M; Greenfield LJ; Upchurch GR; Henke PK
    J Vasc Surg; 2003 May; 37(5):976-83. PubMed ID: 12756342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolism in hospitalized neutropenic cancer patients.
    Khorana AA; Francis CW; Culakova E; Fisher RI; Kuderer NM; Lyman GH
    J Clin Oncol; 2006 Jan; 24(3):484-90. PubMed ID: 16421425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
    Wun T; White RH
    Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary thromboembolism: long term course and clinical epidemiology].
    Echegaray Agara M; Alonso Martínez JL; Urbieta Echezarreta MA; Abínzano Guillén ML; González Arencibia C; Solano Remírez M
    An Med Interna; 2003 Sep; 20(9):451-6. PubMed ID: 14755898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
    Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
    J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.
    Cushman M; Tsai AW; White RH; Heckbert SR; Rosamond WD; Enright P; Folsom AR
    Am J Med; 2004 Jul; 117(1):19-25. PubMed ID: 15210384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
    Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
    BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
    González-Fajardo JA; Martin-Pedrosa M; Castrodeza J; Tamames S; Vaquero-Puerta C
    J Vasc Surg; 2008 Oct; 48(4):953-9. PubMed ID: 18639417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study.
    van Schouwenburg IM; Gansevoort RT; Mahmoodi BK; Visser MM; Kluin-Nelemans HC; Lijfering WM; Veeger NJ
    Br J Haematol; 2012 Oct; 159(2):216-22. PubMed ID: 22924556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.